Long-Term Outcome of Anemic Lower-Risk Myelodysplastic Syndromes Without 5q Deletion Refractory to or Relapsing After Erythropoiesis-Stimulating Agents
Leukemia - United Kingdom
doi 10.1038/leu.2013.16
Full Text
Open PDFAbstract
Available in full text
Date
January 16, 2013
Authors
Publisher
Springer Science and Business Media LLC